Truly Integrated Premium Courier and Clinical Packaging Services

ADCs

How Lessons from Breast Cancer Are Shaping ADC Development Across Solid Tumors

David Alvaro, Ph.D.

Pharma's Almanac

New Technology

What are the key bottlenecks preventing rapid adoption of novel technologies?

Pharma's Almanac

Drug Shortage

What It Actually Takes to Engineer a Drug Supply Chain Out of Shortage

David Alvaro, Ph.D.

Pharma's Almanac

MRD

Measurable Residual Disease Moves Deeper Into Hematologic Cancer Development

Pharma's Almanac

Biosimilars

The Global Division of Labor Behind the Coming Oncology Biosimilar Wave

Pharma's Almanac

Biologics

Commercial Thinking Begins in Clinical Phases

Mathias Kahl

IDT Biologika

Partner Selection

How are organizations balancing cost with regulatory, supply chain, and reputational risk when selecting partners or sites?

Pharma's Almanac

Preparedness

Preparing Manufacturing Networks for the Next Pandemic

Pharma's Almanac

Supply Chain

Supply Chain Resilience in 2026: Any Progress?

Cynthia A. Challener, Ph.D.

Pharma's Almanac

ATMP Supply Chain

Maintaining Resilient Supply Chains for Advanced Therapies

Pharma's Almanac

Site Network

How Regional Sites in a Global Site Network Combine Local Insight with Global Scale

Darin Brimhall, D.O., FACP

Trialmed

Clinical Diversity

Driving Diversity and Accessibility in Clinical Trials Starts at the Community Level

Melissa Choi, M.D.

Trialmed